These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2444083

  • 1. [A study of the use of methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, bleomycin (MVP-CAB) in metastatic transitional cell carcinoma].
    Fujii A, Den S, Nakamura I, Ohshima H, Nagata H, Izumi T, Takechi Y, Kawaida T, Kamidono S, Yasuno H.
    Hinyokika Kiyo; 1987 May; 33(5):697-703. PubMed ID: 2444083
    [Abstract] [Full Text] [Related]

  • 2. [Combination chemotherapy with methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, and bleomycin: MVP-CAB for disseminated urological cancer].
    Fujii A, Morishita S, Nakamura I, Oka Y, Ohshima H, Nagata H, Iwamoto T, Itoh N, Nakagawa Y, Miyazaki S.
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan 20; 25(1):55-62. PubMed ID: 1691254
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct 20; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 4. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer].
    Konami T, Wakabayashi Y, Kim T, Ishida A, Arai Y, Konishi T, Pak K, Takeuchi H, Tomoyoshi T, Watanabe J.
    Hinyokika Kiyo; 1989 Feb 20; 35(2):231-7. PubMed ID: 2472048
    [Abstract] [Full Text] [Related]

  • 5. [Adjuvant chemotherapy with MVP-CAB (methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin and bleomycin) for epithelial tumors of the upper urinary tract].
    Fujii A, Oka N, Murata Y, Higuchi A, Itoh N, Ishikawa J, Tanaka H.
    Nihon Hinyokika Gakkai Zasshi; 1992 Oct 20; 83(10):1609-14. PubMed ID: 1279258
    [Abstract] [Full Text] [Related]

  • 6. [Intraarterial COMPA (cis-diammine-dichloroplatinum (II), vincristine, methotrexate, peplomycin, adriamycin) chemotherapy for bladder cancer].
    Tsujino S, Ito T, Aizawa T, Namiki K, Ohno Y, Yamamoto S, Ishibashi K, Miki M, Yamauchi T, Kawai T.
    Hinyokika Kiyo; 1992 Oct 20; 38(10):1101-7. PubMed ID: 1282770
    [Abstract] [Full Text] [Related]

  • 7. [Combination chemotherapy with methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin, and bleomycin (MVP-CAB) for metastatic urothelial cancer].
    Fujii A, Oka N, Miyasaki S, Higuchi A, Itoh N, Okamoto Y, Tanaka H, Hiro-oka K, Shimatani N, Inoue T.
    Nihon Hinyokika Gakkai Zasshi; 1991 Jun 20; 82(6):932-9. PubMed ID: 1715415
    [Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy for metastatic urinary bladder cancer with 5-FU, vincristine, bleomycin, cyclophosphamide, mitomycin, and methotrexate.
    Kubota Y, Shuin T, Miura T, Moriyama M, Fukushima S, Shiozaki H, Ooshima H.
    Cancer Treat Rep; 1984 Sep 20; 68(9):1167-8. PubMed ID: 6206946
    [Abstract] [Full Text] [Related]

  • 9. [Combination chemotherapy of cyclophosphamide, adriamycin and cisplatin in advanced urothelial cancer].
    Nakagawa S, Nakao M, Toyoda K, Nukui M, Takada H, Ebisui K, Watanabe H, Furusawa T, Maegawa M, Kaiho H.
    Gan To Kagaku Ryoho; 1987 Nov 20; 14(11):3071-7. PubMed ID: 3674892
    [Abstract] [Full Text] [Related]

  • 10. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
    Yamauchi T, Hida S, Ooishi K, Okada K, Yoshida O.
    Hinyokika Kiyo; 1985 Jul 20; 31(7):1093-104. PubMed ID: 2414981
    [Abstract] [Full Text] [Related]

  • 11. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Jul 20; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 12. [Adriamycin, cyclophosphamide, vincristine and methotrexate combination chemotherapy of small cell lung cancer].
    Saito H, Kawatsu H, Saka H, Yamamoto M, Takagi E, Tsunekawa H, Kawachi H, Nagura E, Sakai S, Nishiwaki K.
    Gan To Kagaku Ryoho; 1988 Jun 20; 15(6):1909-13. PubMed ID: 2838000
    [Abstract] [Full Text] [Related]

  • 13. [Combination chemotherapy of advanced transitional cell carcinoma with cis-platinum, cyclophosphamide, adriamycin and 5-fluorouracil (CISCAF)].
    Fujioka H, Tada Y, Nakano E, Matsuda M, Osafune M, Sagawa S, Takaha M, Sonoda T.
    Gan To Kagaku Ryoho; 1984 Aug 20; 11(8):1612-6. PubMed ID: 6541019
    [Abstract] [Full Text] [Related]

  • 14. Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum).
    Jones DH, Bleehen NM, Grant RM, Plowman PN, Roberts JT, Sikora K, Watson JV, Wiltshire CR.
    Anticancer Res; 1983 Aug 20; 3(4):235-8. PubMed ID: 6192751
    [Abstract] [Full Text] [Related]

  • 15. [Adjuvant chemotherapy (MVP-CAB; methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin, and bleomycin) for bladder cancer].
    Fujii A, Oka N, Murata Y, Higuchi A, Itoh N, Nakagawa J, Tanaka H, Izumi T, Yamada Y.
    Nihon Hinyokika Gakkai Zasshi; 1992 May 20; 83(5):619-26. PubMed ID: 1379656
    [Abstract] [Full Text] [Related]

  • 16. Long-term follow-up results of a Pilot Phase II study of multidrug chemotherapy (MVP-CAB) in patients with advanced urothelial cancer.
    Gohji K, Ono Y, Takenaka A, Nomi M, Okamoto M, Yuen K, Fujii A.
    Jpn J Clin Oncol; 1999 Apr 20; 29(4):204-8. PubMed ID: 10340044
    [Abstract] [Full Text] [Related]

  • 17. [Combination chemotherapy with methotrexate (MTX), vincristine (VCR), cisplatinum (CDDP), cyclophosphamide (CPM), adriamycin (ADM), and bleomycin (BLM); MVP-CAB in patients with advanced urothelial tract cancer].
    Fujii A, Morishita S, Nakamura I, Oka Y, Ohshima H, Nagata H, Iwamoto T, Izumi T, Miyasaki Z, Ito N.
    Nihon Hinyokika Gakkai Zasshi; 1988 Jun 20; 79(6):985-93. PubMed ID: 2460657
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Three-drug combination chemotherapy for advanced urothelial tract carcinoma.
    Ohshima S, Ono Y, Fujita T, Aso Y.
    Cancer Chemother Pharmacol; 1987 Jun 20; 20 Suppl():S20-3. PubMed ID: 2444354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.